Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01599715 · ClinicalTrials.gov registry record · Phase 2
Translating Unique Learning for Incontinence Prevention
A Phase 2 study of Urinary Incontinence, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 647
- Enrollment target
- 2
- Study locations
NCT01599715 is a Phase 2 study of Urinary Incontinence that has completed, run by University of Michigan. The registered enrollment target is 647 participants, above the 249-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (160% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT01599715, a Phase 2 study of Urinary Incontinence, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 647 participants
- Enrollment target
- 2
- Study locations
Study Summary
More than one in three US women suffers from the distressing, embarrassing, and often unreported problem of urinary incontinence (UI). UI severity increases with age and the financial cost exceeds $19 billion per year . The Adult Conservative Management Committee of the 2008 International Consultation on Incontinence concluded that pelvic floor muscle training (PFMT) should be offered as first line therapy to all women with stress, urge, or mixed UI; and that bladder training (BT) may be preferred to drug therapy. Conservative strategies are low risk and differ from other forms of UI management in that they do not prejudice future treatments. They also may decrease symptoms of urgency and frequency that do not entail UI, but greatly reduce the quality of life for nearly 1 in 11 US women.
Conditions Studied
Interventions
- BEHAVIORAL Instructional DVD
- BEHAVIORAL Bladder Health Class
Study Locations (2)
Michigan
- University of Michigan School of Nursing - Ann Arbor
Pennsylvania
- University of Pennsylvania Department of Urology - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 647 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01599715
The ClinicalTrials.gov registry entry for NCT01599715 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 647 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 249-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (160% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Instructional DVD is the first listed.
NCT01599715 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01599715 about?
NCT01599715 is a clinical study titled "Translating Unique Learning for Incontinence Prevention". More than one in three US women suffers from the distressing, embarrassing, and often unreported problem of urinary incontinence (UI). UI severity increases with age and the financial cost exceeds $19 billion per year . The Adult Conservative Management Committee of the 2008 International Consultati...
What is the current status of trial NCT01599715?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 647 participants. The study started on 2010-09. Estimated completion is 2015-01.
What conditions does trial NCT01599715 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT01599715?
The interventions under investigation include: Instructional DVD (BEHAVIORAL), Bladder Health Class (BEHAVIORAL).
Who is sponsoring clinical trial NCT01599715?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01599715 being conducted?
This trial has 2 study locations across Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
RECRUITING · Phase 2
-
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
RECRUITING · Phase 2
-
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
RECRUITING · Phase 2
-
Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence
COMPLETED · Phase 2
-
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
COMPLETED · Phase 2
-
Urge Incontinence Bladder Overactivity Study
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.